Patents by Inventor Kenji Hyodo

Kenji Hyodo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210023004
    Abstract: The present invention provides a novel liposome composition containing eribulin or its pharmacologically permissible salt, and its method of manufacture.
    Type: Application
    Filed: October 9, 2020
    Publication date: January 28, 2021
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Hiroshi KIKUCHI, Kenji HYODO, Hiroshi ISHIHARA
  • Publication number: 20210011430
    Abstract: A quantum simulator includes a pseudo speckle pattern generator, a main vacuum chamber, an atomic gas supply unit, a light beam generator, a photodetector, and an atom number detector. The pseudo speckle pattern generator generates a pseudo speckle pattern in the inside of the main vacuum chamber by light allowed to enter the inside of the main vacuum chamber through the second window. The pseudo speckle pattern generator includes a controller, a light source, a beam expander, a spatial light modulator, and a lens. The controller sets a modulation distribution of the spatial light modulator based on a two-dimensional pseudo random number pattern.
    Type: Application
    Filed: September 23, 2020
    Publication date: January 14, 2021
    Applicants: HAMAMATSU PHOTONICS K.K., INTER-UNIVERSITY RESEARCH INSTITUTE CORPORATION NATIONAL INSTITUTES OF NATURAL SCIENCES
    Inventors: Hiroto Sakai, Kenji Ohmori, Taro Ando, Nobuyuki Takei, Haruyoshi Toyoda, Yoshiyuki Ohtake, Tomoko Hyodo, Yuu Takiguchi
  • Patent number: 10824114
    Abstract: A quantum simulator includes a pseudo speckle pattern generator, a main vacuum chamber, an atomic gas supply unit, a light beam generator, a photodetector, and an atom number detector. The pseudo speckle pattern generator generates a pseudo speckle pattern in the inside of the main vacuum chamber by light allowed to enter the inside of the main vacuum chamber through the second window. The pseudo speckle pattern generator includes a controller, a light source, a beam expander, a spatial light modulator, and a lens. The controller sets a modulation distribution of the spatial light modultor based on a two-dimensional pseudo random number pattern.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: November 3, 2020
    Assignees: HAMAMATSU PHOTONICS K.K., INTER-UNIVERSITY RESEARCH INSTITUTE CORPORATION NATIONAL SCIENCES
    Inventors: Hiroto Sakai, Kenji Ohmori, Taro Ando, Nobuyuki Takei, Haruyoshi Toyoda, Yoshiyuki Ohtake, Tomoko Hyodo, Yuu Takiguchi
  • Patent number: 10726911
    Abstract: A memory system according to an embodiment includes a semiconductor memory and a memory controller. The semiconductor memory includes memory cells and a sequencer. Each of the memory cells stores first data when it has a first threshold voltage, and stores second data when it has a second threshold voltage. The sequencer performs a first write operation for write data. In the first write operation, the sequencer executes a program loop repeatedly and terminates the first write operation, when the verify operation for the first data has passed and the verify operation for the second data has not passed. The sequencer performs a second write operation for the write data based on a first command from the memory controller after the first write operation is terminated.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: July 28, 2020
    Assignee: Toshiba Memory Corporation
    Inventors: Kuminori Hyodo, Kenji Sakurada, Masanobu Shirakawa, Hideki Yamada
  • Publication number: 20190295634
    Abstract: A memory system according to an embodiment includes a semiconductor memory and a memory controller. The semiconductor memory includes memory cells and a sequencer. Each of the memory cells stores first data when it has a first threshold voltage, and stores second data when it has a second threshold voltage. The sequencer performs a first write operation for write data. In the first write operation, the sequencer executes a program loop repeatedly and terminates the first write operation, when the verify operation for the first data has passed and the verify operation for the second data has not passed. The sequencer performs a second write operation for the write data based on a first command from the memory controller after the first write operation is terminated.
    Type: Application
    Filed: September 4, 2018
    Publication date: September 26, 2019
    Applicant: Toshiba Memory Corporation
    Inventors: Kuminori HYODO, Kenji SAKURADA, Masanobu SHIRAKAWA, Hideki YAMADA
  • Patent number: 10230087
    Abstract: A non-woven fabric base material for a lithium ion secondary battery separator composed mainly of a polyethylene terephthalate fiber, characterized in that the non-woven fabric base material comprises a polyethylene terephthalate binder fiber and a crystallized polyethylene terephthalate fiber, and the content of a polyethylene terephthalate binder fiber having a fiber length of 2.5 mm or less is 10 to 60 mass %.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: March 12, 2019
    Assignee: MITSUBISHI PAPER MILLS LIMITED
    Inventors: Tomohiro Sato, Toshihiro Shigematsu, Makoto Kato, Kenji Hyodo, Wakana Aizawa
  • Patent number: 10131633
    Abstract: The present invention provides a cationic lipid which can be used for nucleic acid delivery to a cytoplasm and which is possible to solve the problem of physical stability of a lipid complex. This cationic lipid is a compound represented by the general formula (3) or a pharmaceutically acceptable salt thereof: wherein, L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms, R is an alkyl having 1-2 carbon atoms, and n1 and n2 are independently an integer of 1-3.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 20, 2018
    Assignees: Eisai R&D Management Co., Ltd., Sogo Pharmaceutical Co., Ltd.
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Patent number: 10081598
    Abstract: The present invention provides a cationic lipid which can be utilized for nucleic acid delivery into the cytoplasm. The cationic lipid of the present invention is, for example, a compound represented by the following Formula (1) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: September 25, 2018
    Assignees: Eisai R&D Management Co., Ltd., Sogo Pharmaceutical Co., Ltd.
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Patent number: 9968583
    Abstract: The present invention provides a method of manufacture of a liposome composition including a step in which: a liposome dispersion liquid containing a liposome, and further containing cyclodextrin in the liposome internal phase is provided and a step in which an active compound is introduced into said liposome internal phase, and the liposome composition.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: May 15, 2018
    Assignee: EISAI R & D MANAGEMENT CO., LTD.
    Inventors: Hiroshi Kikuchi, Kenji Hyodo, Hiroshi Ishihara
  • Publication number: 20180105493
    Abstract: The present invention provides a cationic lipid which can be used for nucleic acid delivery to a cytoplasm and which is possible to solve the problem of physical stability of a lipid complex. This cationic lipid is a compound represented by the general formula (3) or a pharmaceutically acceptable salt thereof: wherein, L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms, R is an alkyl having 1-2 carbon atoms, and n1 and n2 are independently an integer of 1-3.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 19, 2018
    Applicants: Eisai R&D Management Co., Ltd., Sogo Pharmaceutical Co., Ltd.
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Patent number: 9873669
    Abstract: The present invention provides a cationic lipid which can be used for nucleic acid delivery to a cytoplasm and which is possible to solve the problem of physical stability of a lipid complex. This cationic lipid is a compound represented by the general formula (3) or a pharmaceutically acceptable salt thereof: wherein, L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms, R is an alkyl having 1-2 carbon atoms, and n1 and n2 are independently an integer of 1-3.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: January 23, 2018
    Assignees: Eisai R&D Management Co., Ltd., Sogo Pharmaceutical Co., Ltd.
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Publication number: 20170334852
    Abstract: The present invention provides a cationic lipid which can be utilized for nucleic acid delivery into the cytoplasm. The cationic lipid of the present invention is, for example, a compound represented by the following Formula (1) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 24, 2015
    Publication date: November 23, 2017
    Applicants: Eisai R&D Management Co., Ltd., Sogo Pharmaceutical Co., Ltd.
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Publication number: 20170288190
    Abstract: A non-woven fabric base material for a lithium ion secondary battery separator composed mainly of a polyethylene terephthalate fiber, characterized in that the non-woven fabric base material comprises a polyethylene terephthalate binder fiber and a crystallized polyethylene terephthalate fiber, and the content of a polyethylene terephthalate binder fiber having a fiber length of 2.5 mm or less is 10 to 60 mass %.
    Type: Application
    Filed: June 23, 2017
    Publication date: October 5, 2017
    Applicant: MITSUBISHI PAPER MILLS LIMITED
    Inventors: Tomohiro SATO, Toshihiro SHIGEMATSU, Makoto KATO, Kenji HYODO, Wakana AIZAWA
  • Patent number: 9768430
    Abstract: A non-woven fabric base material for a lithium ion secondary battery separator composed mainly of a polyethylene terephthalate fiber, characterized in that the non-woven fabric base material comprises a polyethylene terephthalate binder fiber and a crystallized polyethylene terephthalate fiber, and the content of a polyethylene terephthalate binder fiber having a fiber length of 2.5 mm or less is 10 to 60 mass %.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: September 19, 2017
    Assignee: MITSUBISHI PAPER MILLS LIMITED
    Inventors: Tomohiro Sato, Toshihiro Shigematsu, Makoto Kato, Kenji Hyodo, Wakana Aizawa
  • Publication number: 20160326116
    Abstract: The present invention provides a cationic lipid which can be used for nucleic acid delivery to a cytoplasm and which is possible to solve the problem of physical stability of a lipid complex. This cationic lipid is a compound represented by the general formula (3) or a pharmaceutically acceptable salt thereof: wherein, L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms, R is an alkyl having 1-2 carbon atoms, and n1 and n2 are independently an integer of 1-3.
    Type: Application
    Filed: January 7, 2015
    Publication date: November 10, 2016
    Inventors: Yuta Suzuki, Kenji Hyodo, Yohei Tanaka
  • Publication number: 20150372269
    Abstract: A non-woven fabric base material for a lithium ion secondary battery separator composed mainly of a polyethylene terephthalate fiber, characterized in that the non-woven fabric base material comprises a polyethylene terephthalate binder fiber and a crystallized polyethylene terephthalate fiber, and the content of a polyethylene terephthalate binder fiber having a fiber length of 2.5 mm or less is 10 to 60 mass %.
    Type: Application
    Filed: January 28, 2014
    Publication date: December 24, 2015
    Applicant: Mitsubishi Paper Mills Limited
    Inventors: Tomohiro SATO, Toshihiro SHIGEMATSU, Makoto KATO, Kenji HYODO, Wakana AIZAWA
  • Patent number: 8878709
    Abstract: Disclosed herein is a semiconductor integrated circuit including: line buffers; an alpha channel first selector; an alpha channel digital-to-analog converter; a beta channel digital-to-analog converter; a redundant digital-to-analog converter; an alpha channel second selector; a beta channel second selector; an alpha channel amplifier; and a beta channel amplifier.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: November 4, 2014
    Assignee: Sony Corporation
    Inventors: Kenji Hyodo, Takashi Ichirizuka, Takuya Kimoto, Minoru Togo
  • Publication number: 20140044777
    Abstract: The present invention provides a novel liposome composition containing eribulin or its pharmacologically permissible salt, and its method of manufacture.
    Type: Application
    Filed: October 23, 2013
    Publication date: February 13, 2014
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Hiroshi KIKUCHI, Kenji HYODO, Hiroshi ISHIHARA
  • Patent number: 8406614
    Abstract: Auxiliary AV data of a lower rate is formed in an auxiliary AV data converting unit on the basis of video and audio data of a main line system. The audio data of the main line system in which the number of channels is equal to 0 and 4 or 8 channels can exist mixedly. In the auxiliary AV data, the number of channels of the audio data is fixed to 8 channels. Audio data showing silence is outputted to the channels which do not correspond to the channels of the audio data of the main line system of the auxiliary AV data. Since the number of channels of the audio data of the auxiliary AV data is fixed irrespective of the number of channels of the audio data of the main line system, the editing or searching operation using the auxiliary AV data can be executed without paying attention to a change in the number of channels of the audio data of the main line system, or the like.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: March 26, 2013
    Assignee: Sony Corporation
    Inventor: Kenji Hyodo
  • Publication number: 20120128757
    Abstract: The present invention provides a method of manufacture of a liposome composition including a step in which: a liposome dispersion liquid containing a liposome, and further containing cyclodextrin in the liposome internal phase is provided and a step in which an active compound is introduced into said liposome internal phase, and the liposome composition.
    Type: Application
    Filed: March 30, 2010
    Publication date: May 24, 2012
    Applicant: EISAI R&D MANAGEMENT CO., LTD
    Inventors: Hiroshi Kikuchi, Kenji Hyodo, Hiroshi Ishihara